Profound Medical Corp. (TSX: PRN)

Profound Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	27.12	26.21	46.52	67.15	83.91	14.8
Cash & Short-Term Investments	27.12	26.21	46.52	67.15	83.91	14.8
Cash Growth	-19.34%	-43.65%	-30.73%	-19.97%	466.98%	-51.77%
Accounts Receivable	6.95	6.75	5.84	1.41	6.45	1.99
Other Receivables	0.09	0.53	0.51	-	0.99	1.32
Receivables	7.03	7.29	6.34	1.41	7.43	3.31
Inventory	6.44	6.99	7.94	7.41	5.33	3.67
Prepaid Expenses	0.3	1.41	1.22	1.15	1.07	1.03
Total Current Assets	40.88	41.9	62.02	77.13	97.74	22.81
Property, Plant & Equipment	1.02	1.53	1.72	1.9	2.28	2.22
Goodwill	-	-	-	2.69	2.68	2.63
Other Intangible Assets	0.33	0.49	0.68	1.44	1.9	2.41
Long-Term Accounts Receivable	-	-	-	3.62	-	-
Total Assets	42.24	43.91	64.42	86.78	104.6	30.06
Accounts Payable	3.4	3.28	2.03	3.18	3.38	3.03
Current Portion of Long-Term Debt	2.2	2.1	0.52	-	-	3.96
Current Portion of Leases	0.27	0.26	0.24	0.25	0.31	0.2
Current Income Taxes Payable	0.02	-	0.3	-	0.01	0.01
Current Unearned Revenue	0.8	0.72	0.47	0.48	0.36	0.5
Other Current Liabilities	-	-	0.62	0.25	0.74	0.52
Total Current Liabilities	6.68	6.37	4.19	4.16	4.81	8.22
Long-Term Debt	3.4	5	6.65	-	-	5.17
Long-Term Leases	0.37	0.58	0.82	1.13	1.36	1.64
Long-Term Unearned Revenue	0.67	0.73	0.76	0.88	1.08	0.64
Long-Term Deferred Tax Liabilities	0.06	0.06	-	-	-	-
Other Long-Term Liabilities	-	-	-	-	-	0.02
Total Liabilities	11.17	12.73	12.42	6.16	7.25	15.69
Common Stock	235.67	217.39	205.83	219.58	211.53	100.3
Additional Paid-In Capital	19.41	19.69	18.7	16.99	11.25	15.08
Retained Earnings	-240.41	-217.93	-189.36	-160.69	-129.99	-108.37
Comprehensive Income & Other	16.39	12.03	16.84	4.75	4.57	7.37
Shareholders' Equity	31.06	31.18	52	80.62	97.35	14.37
Total Liabilities & Equity	42.24	43.91	64.42	86.78	104.6	30.06
Total Debt	6.23	7.94	8.23	1.38	1.68	10.97
Net Cash (Debt)	20.9	18.27	38.29	65.78	82.24	3.83
Net Cash Growth	-18.06%	-52.28%	-41.79%	-20.02%	2047.74%	-79.56%
Net Cash Per Share	0.88	0.86	1.84	3.21	4.76	0.34
Filing Date Shares Outstanding	24.66	24.43	20.91	20.78	20.29	15.69
Total Common Shares Outstanding	24.66	21.37	20.88	20.78	20.21	11.85
Working Capital	34.21	35.53	57.84	72.97	92.93	14.58
Book Value Per Share	1.26	1.46	2.49	3.88	4.82	1.21
Tangible Book Value	30.74	30.69	51.32	76.49	92.77	9.34
Tangible Book Value Per Share	1.25	1.44	2.46	3.68	4.59	0.79
Machinery	2.81	0.54	0.54	1.2	1.83	1.25
Leasehold Improvements	0.54	2.58	1.84	0.58	0.55	0.55

Source: S&P Capital IQ. Standard template. Financial Sources.